| Literature DB >> 33044871 |
Jing Ren1, Yao Zheng1, Hui Du2, Shan Wang3, Linna Liu1, Wanshi Duan4, Zeping Zhang5, Lijun Heng6, Qi Yang1.
Abstract
Black hairy tongue (BHT) is characterized by a discolored, hairy tongue. We herein report two cases of BHT associated with antibacterial agents and review previous cases. In Case 1, a 17-year-old girl with a central neurocytoma was administered intravenous piperacillin-tazobactam for postoperative infection, and BHT developed 12 days later. Her symptoms resolved 8 days after she discontinued the piperacillin-tazobactam and brushed her tongue three times daily. In Case 2, a 65-year-old man was administered intravenous piperacillin-tazobactam and levofloxacin to treat multidrug-resistant Pseudomonas aeruginosa, and BHT developed 15 days later. The piperacillin-tazobactam was discontinued and the patient brushed his tongue, and the discoloration gradually subsided thereafter. However, the BHT reappeared after linezolid treatment. The patient had adverse drug reactions to both the piperacillin-tazobactam and linezolid treatments. The BHT might have been related to antibiotic use in both cases. We identified 19 cases of antibiotic-related BHT in a literature search, but none were related to piperacillin-tazobactam use. In all cases, symptoms resolved after discontinuation of the drug and brushing of the tongue. BHT may be a rare adverse effect of antibiotics. Treatment strategies include removal of the causative agents, mechanical debridement, and good oral hygiene.Entities:
Keywords: Black hairy tongue; Naranjo algorithm; adverse drug reaction; case report; literature review; piperacillin–tazobactam
Mesh:
Substances:
Year: 2020 PMID: 33044871 PMCID: PMC7556181 DOI: 10.1177/0300060520961279
Source DB: PubMed Journal: J Int Med Res ISSN: 0300-0605 Impact factor: 1.671
Figure 1.Case 1. (a) Black hairy tongue in a 17-year-old girl receiving piperacillin–tazobactam. (b) Image of the patient’s tongue 2 days after stopping piperacillin–tazobactam and brushing the tongue.
Figure 2.Case 2. (a) Black hairy tongue in a 65-year-old man receiving piperacillin–tazobactam. (b) Image of the patient’s tongue 13 days after discontinuing treatment on 25 December.
Naranjo adverse drug reaction causality scale scores.
| Question | Score | ||
|---|---|---|---|
| Case 1 | Case 2 (P) | Case 2 (L) | |
| 1. Are there previous conclusive reports on this reaction? | 0 | 0 | +1 |
| 2. Did the adverse event appear after the suspected drug was administered? | +2 | +2 | +2 |
| 3. Did the adverse event improve when the drug was discontinued or a specific antagonist was administered? | +1 | +1 | +1 |
| 4. Did the adverse event reappear when the drug was readministered? | 0 | 0 | 0 |
| 5. Are there alternative causes that could have caused the reaction on their own? | +2 | −1 | +2 |
| 6. Did the reaction reappear when a placebo was given? | 0 | +1 | 0 |
| 7. Was the drug detected in blood or other fluids in concentrations known to be toxic? | 0 | 0 | 0 |
| 8. Was the reaction more severe when the dose was increased or less severe when the dose was decreased? | 0 | 0 | 0 |
| 9. Did the patient have a similar reaction to the same or similar drugs in any previous exposure? | 0 | 0 | +1 |
| 10. Was the adverse event confirmed by any objective evidence? | 0 | 0 | 0 |
| Total score | 5 | 3 | 7 |
| Score | Probability of ADR | ||
| ≥9 | Definite | ||
| 5–8 | Probable | ||
| 1–4 | Possible | ||
| ≤0 | Doubtful | ||
P, piperacillin–tazobactam; L, linezolid; ADR, adverse drug reaction.
Source: Reference 5.
Summary of cases of antibiotic-associated black hairy tongue from the literature and two cases at our institution
| Authors/year (reference) | Age/Sex | Suspected antibiotics | Symptoms | Microbiologic findings | Treatment | Duration | Recovery time | Possible risk factors | Naranjo score |
|---|---|---|---|---|---|---|---|---|---|
| Kim et al. 2002 (6) | 55/M | Minocycline | Black hairy tongue | None | Discontinued minocycline | 7 weeks | NR | Smoking and drinking | NR |
| Ramsakal and Mangat 2007 (7) | 24/M | Doxycycline | Black discoloration and hairy appearance of the tongue | Throat culture was positive | Discontinued doxycycline and underwent treatment with a short course of fluconazole | 1 week | 3 days | NR | NR |
| Pigatto et al. 2008 (8) | 40/M | Erythromycin | Black-brownish hairy tongue with nail discoloration | Culture of tongue swab specimen was positive for | Discontinued oral erythromycin | 5 months | Gradually improved | Smoking and drinking alcohol and coffee | NR |
| Refaat et al. 2008 (9) | 74/M | Linezolid | Black coating on the surface of the tongue with hairy elevations | None | Discontinued linezolid | 2 days | 3 days | NR | 6 |
| Sheikh et al. 2011 (10) | 53/F | Amoxicillin, clavulanate, and metronidazole | Black discoloration of the tongue | Tongue scrapings confirmed | Short course of fluconazole | 1 week | Within 7 days | High intake of caffeinated drinks | NR |
| Bozkurt et al. 2012 (11) | 40/F | Linezolid | Black hairy discoloration on the tongue, especially on the right side | NR | Brushed and practiced good oral hygiene | 10 days | Nearly 1 week | NR | 6 |
| Khasawneh et al. 2013 (12) | 56/M | Linezolid | Blackish discoloration of the tongue and dysgeusia | ND | Finished the antibiotic course and cleaned the tongue with a soft toothbrush and baking soda-containing toothpaste twice daily | 4 days | 4 weeks later | Edentulous with poor oral hygiene | 6 |
| Aijazi and Abdulla 2014 (13) | 62/F | Linezolid | Black hairy discoloration of the tongue | NR | Discontinued the antibiotic and improved oral dental hygiene | 2 weeks | 3 weeks | Very poor oral hygiene | NR |
| Balaji et al. 2014 (14) | 10/M | Linezolid | Black to brown hairy tongue | ND | Stopped the use of oral linezolid and cleaned the tongue with normal saline twice daily | 14 days | 11 days | NR | 5 |
| Jain et al. 2017 (15) | 25/M | Linezolid | Black colored/hairy tongue | NR | Withdrew linezolid and cleaned tongue | 10–15 days | 15 days | NR | 6 |
| 30/F | Linezolid | Black hairy tongue | NR | Withdrew linezolid and cleaned the tongue with a soft brush | 15 days | 10 days | NR | 6 | |
| Raj et al. 2016 (16) | 26/M | Linezolid | Yellow to brown hairy tongue | ND | Withdrew linezolid | 10 days | 7 days | None | 10 |
| Braga-Simões and Santos 2016 (17) | 52/M | Linezolid | Hairy tongue sensation, dark discoloration, xerostomia, and dysgeusia | NR | Withdrew linezolid | Unknown | 3 weeks | None | 7 |
| Kuo and Fazel 2017 (18) | 65/M | Metronidazole | Brown plaque on the dorsal tongue | NR | Used nystatin oral suspension for 4 days with minimal improvement, then applied topical tretinoin 0.1% cream to the tongue nightly and brushed the tongue with a hard-bristle toothbrush daily | 2 weeks | 1 month | NR | NR |
| Braggio et al. 2018 (19) | 80/M | Linezolid | Swelling and discoloration of the tongue | NR | Withdrew drug | 2 weeks | 2 weeks | NR | NR |
| Hamad and Warren 2018 (20) | 55/F | Minocycline | Black discoloration of the tongue | NR | Withdrew drug and practiced good hygiene | 1 week | Within 4 weeks | NR | NR |
| Negri et al. 2018 (21) | 59/F | Amoxicillin + clavulanate | Hypertrophic and hyperpigmented tongue | NR | NR | 3 days | 5 days | NR | 4 |
| 7/F | Amoxicillin + clavulanate | Black hairy tongue | NR | Withdrew drug | 12 days | NR | NR | 8 | |
| 38/M | Amoxicillin + clavulanate | Black hairy tongue | NR | Withdrew drug | 1 day | NR | NR | 4 | |
| Present cases2020–2021 | 17/F | Piperacillin–tazobactam and SMZ-TMP | Brown to black discoloration with hairy coating | ND | Withdrew drug and cleaned tongue with soft-bristle toothbrush three times a day | 12 days | 10 days | None | 5 |
| 65/M | Piperacillin–tazobactam | Brown to black discoloration with hairy coating | None | Withdrew drug and cleaned tongue with soft-bristle toothbrush three times a day | 15 days | 13 days | Recent use of mouthwash | 3 | |
| Linezolid | Brown to black discoloration with a hairy coating | ND | Completed a 1-month course and brushed the tongue | 2–3 weeks | 10 days after discontinuation of linezolid | None | 7 |
M, male; F, female; NR, not reported; ND, not detected; SMZ-TMP, sulfamethoxazole–trimethoprim